诱导免疫化疗在最初无法切除的食道状细胞癌中,比化疗产生更高的转化率和更好的整体生存率

Shujie Huang1, Sichao Wang2,3, Zhen Gao4

  • 1Department of Anatomical and Cellular Pathology, State Key Laboratory of Translational Oncology, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong, China.

PubMed
概括

诱导免疫化疗 (iIC) 显著改善了不可切割的食道状细胞癌的手术转换和整体存活率 (OS). 这种方法提供了更好的治疗选择,增强了病理反应和患者的结果.